{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:28:43Z","timestamp":1776324523554,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YFC2301801"],"award-info":[{"award-number":["2021YFC2301801"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-93778-9","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T01:20:00Z","timestamp":1743124800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Accelerators of chronic hepatitis B fibrosis cirrhosis CCND1 gene expression and promoter hypomethylation"],"prefix":"10.1038","volume":"15","author":[{"given":"Nan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuna","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"93778_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone, M. & Guidotti, L. G. Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22, 19\u201332. https:\/\/doi.org\/10.1038\/s41577-021-00549-4 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"93778_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cld.2016.06.003","volume":"20","author":"DC Rockey","year":"2016","unstructured":"Rockey, D. C. Liver fibrosis reversion after suppression of hepatitis B virus. Clin. Liver Dis. 20, 667\u2013679. https:\/\/doi.org\/10.1016\/j.cld.2016.06.003 (2016).","journal-title":"Clin. Liver Dis."},{"key":"93778_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.3389\/fimmu.2019.02048","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen, Y. & Tian, Z. HBV-induced immune imbalance in the development of HCC. Front. Immunol. 10, 2048. https:\/\/doi.org\/10.3389\/fimmu.2019.02048 (2019).","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"93778_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/liv.12710","volume":"35","author":"P Bedossa","year":"2015","unstructured":"Bedossa, P. Reversibility of hepatitis B virus cirrhosis after therapy: Who and why?. Liver Int. 35(Suppl 1), 78\u201381. https:\/\/doi.org\/10.1111\/liv.12710 (2015).","journal-title":"Liver Int."},{"key":"93778_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00535-022-01890-8","volume":"57","author":"SMF Akbar","year":"2022","unstructured":"Akbar, S. M. F., Yoshida, O. & Hiasa, Y. Immune therapies against chronic hepatitis B. J. Gastroenterol. 57, 517\u2013528. https:\/\/doi.org\/10.1007\/s00535-022-01890-8 (2022).","journal-title":"J. Gastroenterol."},{"key":"93778_CR6","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","volume":"25","author":"TY Li","year":"2019","unstructured":"Li, T. Y., Yang, Y., Zhou, G. & Tu, Z. K. Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J. Gastroenterol. 25, 3527\u20133537. https:\/\/doi.org\/10.3748\/wjg.v25.i27.3527 (2019).","journal-title":"World J. Gastroenterol."},{"key":"93778_CR7","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.3748\/wjg.v21.i38.10721","volume":"21","author":"LS Cheng","year":"2015","unstructured":"Cheng, L. S., Liu, Y. & Jiang, W. Restoring homeostasis of CD4\u207a T cells in hepatitis-B-virus-related liver fibrosis. World J. Gastroenterol. 21, 10721\u201310731. https:\/\/doi.org\/10.3748\/wjg.v21.i38.10721 (2015).","journal-title":"World J. Gastroenterol."},{"key":"93778_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jgh.13811","volume":"33","author":"YP Chen","year":"2018","unstructured":"Chen, Y. P. et al. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection. J. Gastroenterol. Hepatol. 33, 256\u2013263. https:\/\/doi.org\/10.1111\/jgh.13811 (2018).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"93778_CR9","doi-asserted-by":"publisher","first-page":"1133543","DOI":"10.3389\/fimmu.2023.1133543","volume":"14","author":"YM Bai","year":"2023","unstructured":"Bai, Y. M., Liang, S. & Zhou, B. Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: Based on bioinformatics, transcriptomics and q-PCR experiments. Front. Immunol. 14, 1133543. https:\/\/doi.org\/10.3389\/fimmu.2023.1133543 (2023).","journal-title":"Front. Immunol."},{"key":"93778_CR10","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.3748\/wjg.v28.i27.3503","volume":"28","author":"MJ Liao","year":"2022","unstructured":"Liao, M. J. et al. Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China. World J. Gastroenterol. 28, 3503\u20133513. https:\/\/doi.org\/10.3748\/wjg.v28.i27.3503 (2022).","journal-title":"World J. Gastroenterol."},{"key":"93778_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2036.2008.03895.x","volume":"29","author":"V Mallet","year":"2009","unstructured":"Mallet, V. et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol. Ther. 29, 409\u2013415. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03895.x (2009).","journal-title":"Aliment Pharmacol. Ther."},{"key":"93778_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158754","author":"Y Osaki","year":"2022","unstructured":"Osaki, Y. et al. Blocking cell cycle progression through CDK4\/6 protects against chronic kidney disease. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.158754 (2022).","journal-title":"JCI Insight"},{"key":"93778_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112689","volume":"253","author":"MJ Shi","year":"2020","unstructured":"Shi, M. J. et al. A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis. J. Ethnopharmacol. 253, 112689. https:\/\/doi.org\/10.1016\/j.jep.2020.112689 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"93778_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/ijmm.2018.3689","volume":"42","author":"M Katoh","year":"2018","unstructured":"Katoh, M. Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2-catenin signaling activation (Review). Int. J. Mol. Med. 42, 713\u2013725. https:\/\/doi.org\/10.3892\/ijmm.2018.3689 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"93778_CR15","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3389\/fimmu.2020.01620","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. CCND1 amplification contributes to immunosuppression and is associated with a poor prognosis to immune checkpoint inhibitors in solid tumors. Front. Immunol. 11, 1620. https:\/\/doi.org\/10.3389\/fimmu.2020.01620 (2020).","journal-title":"Front. Immunol."},{"key":"93778_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","volume":"20","author":"B Luo","year":"2022","unstructured":"Luo, B. et al. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med. 20, 8. https:\/\/doi.org\/10.1186\/s12916-021-02201-3 (2022).","journal-title":"BMC Med."},{"key":"93778_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13148-016-0218-1","volume":"8","author":"M Zeybel","year":"2016","unstructured":"Zeybel, M. et al. DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease. Clin. Epigenet. 8, 48. https:\/\/doi.org\/10.1186\/s13148-016-0218-1 (2016).","journal-title":"Clin. Epigenet."},{"key":"93778_CR18","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.3748\/wjg.v26.i45.7088","volume":"26","author":"XY Xu","year":"2020","unstructured":"Xu, X. Y. et al. Chinese guidelines on the management of liver cirrhosis (abbreviated version). World J. Gastroenterol. 26, 7088\u20137103. https:\/\/doi.org\/10.3748\/wjg.v26.i45.7088 (2020).","journal-title":"World J. Gastroenterol."},{"key":"93778_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cld.728","volume":"12","author":"NA Terrault","year":"2018","unstructured":"Terrault, N. A. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Clin. Liver Dis. (Hoboken) 12, 33\u201334. https:\/\/doi.org\/10.1002\/cld.728 (2018).","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"93778_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1073","volume":"12","author":"L Shao","year":"2022","unstructured":"Shao, L. et al. Biopsy-based single-cell transcriptomics reveals MAIT cells as potential targets for controlling fibrosis-related liver inflammation due to chronic hepatitis-B infection. Clin. Transl. Med. 12, e1073. https:\/\/doi.org\/10.1002\/ctm2.1073 (2022).","journal-title":"Clin. Transl. Med."},{"key":"93778_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/apt.13271","volume":"42","author":"S Gao","year":"2015","unstructured":"Gao, S. et al. Aberrant GSTP1 promoter methylation predicts short-term prognosis in acute-on-chronic hepatitis B liver failure. Aliment Pharmacol. Ther. 42, 319\u2013329. https:\/\/doi.org\/10.1111\/apt.13271 (2015).","journal-title":"Aliment Pharmacol. Ther."},{"key":"93778_CR22","doi-asserted-by":"publisher","first-page":"1106952","DOI":"10.3389\/fgene.2023.1106952","volume":"14","author":"D Chen","year":"2023","unstructured":"Chen, D. et al. KLF4 loss in hepatocellular carcinoma: Improving prognostic prediction and correlating immune infiltrates. Front. Genet. 14, 1106952. https:\/\/doi.org\/10.3389\/fgene.2023.1106952 (2023).","journal-title":"Front. Genet."},{"key":"93778_CR23","doi-asserted-by":"publisher","first-page":"4917","DOI":"10.2147\/cmar.S192529","volume":"11","author":"H Ren","year":"2019","unstructured":"Ren, H. et al. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer. Cancer Manag. Res. 11, 4917\u20134930. https:\/\/doi.org\/10.2147\/cmar.S192529 (2019).","journal-title":"Cancer Manag. Res."},{"key":"93778_CR24","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.3748\/wjg.v20.i21.6457","volume":"20","author":"J Lin","year":"2014","unstructured":"Lin, J., Wu, J. F., Zhang, Q., Zhang, H. W. & Cao, G. W. Virus-related liver cirrhosis: Molecular basis and therapeutic options. World J. Gastroenterol. 20, 6457\u20136469. https:\/\/doi.org\/10.3748\/wjg.v20.i21.6457 (2014).","journal-title":"World J. Gastroenterol."},{"key":"93778_CR25","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1073\/pnas.0510801103","volume":"103","author":"J Lee","year":"2006","unstructured":"Lee, J. et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 103, 1828\u20131833. https:\/\/doi.org\/10.1073\/pnas.0510801103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"93778_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1093616","volume":"303","author":"SS Diebold","year":"2004","unstructured":"Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529\u20131531. https:\/\/doi.org\/10.1126\/science.1093616 (2004).","journal-title":"Science"},{"key":"93778_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.antiviral.2012.10.001","volume":"96","author":"J Chang","year":"2012","unstructured":"Chang, J., Block, T. M. & Guo, J. T. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy. Antiviral Res. 96, 405\u2013413. https:\/\/doi.org\/10.1016\/j.antiviral.2012.10.001 (2012).","journal-title":"Antiviral Res."},{"key":"93778_CR28","doi-asserted-by":"publisher","first-page":"1206720","DOI":"10.3389\/fcimb.2023.1206720","volume":"13","author":"P Zheng","year":"2023","unstructured":"Zheng, P., Dou, Y. & Wang, Q. Immune response and treatment targets of chronic hepatitis B virus infection: Innate and adaptive immunity. Front. Cell Infect. Microbiol. 13, 1206720. https:\/\/doi.org\/10.3389\/fcimb.2023.1206720 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"93778_CR29","doi-asserted-by":"publisher","first-page":"114922","DOI":"10.1016\/j.biopha.2023.114922","volume":"164","author":"MH Alu\u2019datt","year":"2023","unstructured":"Alu\u2019datt, M. H. et al. Royal jelly mediates fibrotic signaling, collagen cross-linking and cell proliferation in cardiac fibroblasts. Biomed. Pharmacother. 164, 114922. https:\/\/doi.org\/10.1016\/j.biopha.2023.114922 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"93778_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30086","volume":"10","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. Identification of shared molecular mechanisms and diagnostic biomarkers between heart failure and idiopathic pulmonary fibrosis. Heliyon 10, e30086. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30086 (2024).","journal-title":"Heliyon"},{"key":"93778_CR31","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1038\/s41467-023-42058-z","volume":"14","author":"Y Tsuchiya","year":"2023","unstructured":"Tsuchiya, Y. et al. Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat. Commun. 14, 6304. https:\/\/doi.org\/10.1038\/s41467-023-42058-z (2023).","journal-title":"Nat. Commun."},{"key":"93778_CR32","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.4161\/cc.7.14.6274","volume":"7","author":"LK Mullany","year":"2008","unstructured":"Mullany, L. K. et al. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle 7, 2215\u20132224. https:\/\/doi.org\/10.4161\/cc.7.14.6274 (2008).","journal-title":"Cell Cycle"},{"key":"93778_CR33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","volume":"145","author":"SK Murphy","year":"2013","unstructured":"Murphy, S. K. et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 145, 1076\u20131087. https:\/\/doi.org\/10.1053\/j.gastro.2013.07.047 (2013).","journal-title":"Gastroenterology"},{"key":"93778_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-015-0056-6","volume":"7","author":"M Zeybel","year":"2015","unstructured":"Zeybel, M. et al. Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. Clin. Epigenet. 7, 25. https:\/\/doi.org\/10.1186\/s13148-015-0056-6 (2015).","journal-title":"Clin. Epigenet."},{"key":"93778_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/jvh.12048","volume":"20","author":"Q Zhao","year":"2013","unstructured":"Zhao, Q. et al. DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B. J. Viral Hepat. 20, 430\u2013437. https:\/\/doi.org\/10.1111\/jvh.12048 (2013).","journal-title":"J. Viral Hepat."},{"key":"93778_CR36","doi-asserted-by":"publisher","first-page":"e20326","DOI":"10.1097\/md.0000000000020326","volume":"99","author":"HH Liu","year":"2020","unstructured":"Liu, H. H. et al. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma. Medicine (Baltimore) 99, e20326. https:\/\/doi.org\/10.1097\/md.0000000000020326 (2020).","journal-title":"Medicine (Baltimore)"},{"key":"93778_CR37","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke, F. & Zimmermann, H. W. Macrophage heterogeneity in liver injury and fibrosis. J. Hepatol. 60, 1090\u20131096. https:\/\/doi.org\/10.1016\/j.jhep.2013.12.025 (2014).","journal-title":"J. Hepatol."},{"key":"93778_CR38","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/a-1957-6384","volume":"42","author":"Y Koda","year":"2022","unstructured":"Koda, Y., Nakamoto, N. & Kanai, T. Regulation of progression and resolution of liver fibrosis by immune cells. Semin. Liver Dis. 42, 475\u2013488. https:\/\/doi.org\/10.1055\/a-1957-6384 (2022).","journal-title":"Semin. Liver Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93778-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93778-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T01:20:05Z","timestamp":1743124805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-93778-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["93778"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-93778-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study was approved by the Ethics Committee of Qilu Hospital of Shandong University, according to the guidelines of the 1975 Declaration of Helsinki. All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"10630"}}